Doceree launches NEXT Marketing Lab for pharma marketers

Doceree, a leading platform for HCP programmatic marketing with proprietary data tools, has unveiled another ground-breaking initiative for the life sciences industry, The NEXT Marketing Lab.
 
The innovation lab is focused on finding solutions to one of the biggest problems facing the pharmaceutical industry: data intricacies, especially rigid data silos, that hinder commercial team collaboration, informed decision-making, next-gen research and clinical transformation. Curated for Doceree clients, who will gain exclusive access to the solution, The NEXT Marketing Lab will use proprietary cross-functional collaboration methodologies to identify tailored, next generation data strategies and solutions that maximize outcomes.
 
Doceree, a well-known multinational pharmaceutical technology firm based on unique technology and data tools, aims to reinvent data solutions for marketing, sales, and access teams to plan, execute, and expand HCP communications supported by timely actionable insights.
 
“The pharma landscape has evolved drastically with the industry waking up to the new reality of digital and incorporating the same into its fold to target HCPs across online platforms. The new scenario is a lot different from how data was traditionally collected in a controlled manner. The digital push has led to innumerable, vast and unstructured HCP datasets that are difficult to exploit for valuable insights that can drive key business decisions to make HCP communications more effective in terms of precision, timing and relevance,” said Harshit Jain MD, founder & global CEO, Doceree.
 
“We are guided by the vision of transforming the pharma messaging landscape. It is with this intent we have launched our latest initiative to break big data silos and bring value to pharma marketing by structuring scattered data points. As opposed to how unreal big data in the pharma sector may have looked, it is now a reality the industry can’t escape, and its potential can’t be ignored. The lab will greatly facilitate marketers to use and share data with ease and work with HCP datasets holistically to enhance internal and external collaborations to support innovation. This is the kind of value creation we aim to make for our partners as we assist them in their business growth,” added Jain.
 
Doceree will work with life sciences organizations to research and develop data strategies and solutions that are tailored to their particular requirements. Doceree is supported by a team of professionals with considerable experience in pharmaceutical marketing, medical, consulting, data science, and technology. The collaborations between the NEXT Marketing Lab and other organizations can be specifically designed to address a variety of issues, including cross-functional information sharing, accurate HCP behavior modeling, physician-level customisation, and compliance RWD integration.
 
The NEXT Marketing Lab will utilize Doceree's 4D methodology to identify commercial challenges, identify viable data solutions, prioritize impact, and deliver a phased roadmap for achieving goals.
 
“Doceree’s The NEXT Marketing Lab is designed to help marketers not only explore transformational data opportunities, but also to cross the chasm between innovative ideas and impactful market solutions,” said Kate Miller, executive vice president of strategy at Doceree.
 
“At Doceree, our mission is to push how data and technology can enhance the digital experience for the benefit of healthcare providers and their patients. The NEXT Marketing Lab is a significant milestone in fulfilling this vision,” noted Miller.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!